Teligent, Inc., formerly IGI Laboratories, Inc., is a specialty generic pharmaceutical company. The Company markets and sells generic injectable pharmaceutical products under its own label in the United States and Canada. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It has two platforms: developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its current contract manufacturing and formulation services business. Its pipeline includes over 30 Abbreviated New Drug Applications filed with the United States Food and Drug Administration for additional pharmaceutical products. It holds additional over 40 product candidates at various stages of its development pipeline, 10 of which are on stability testing.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: N/A
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: TLGT
- Previous Close: $7.40
- 50 Day Moving Average: $7.07
- 200 Day Moving Average: $7.27
- 52-Week Range: $4.46 - $8.66
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 45.19
- P/E Growth: 8.27
- Market Cap: $384.09M
- Outstanding Shares: 53,125,000
- Beta: 1.51
- Net Margins: -20.85%
- Return on Equity: -0.38%
- Return on Assets: -0.13%
Companies Related to Teligent:
- Debt-to-Equity Ratio: 1.83%
- Current Ratio: 8.48%
- Quick Ratio: 7.49%
What is Teligent's stock symbol?
Teligent trades on the NASDAQ under the ticker symbol "TLGT."
Where is Teligent's stock going? Where will Teligent's stock price be in 2017?
5 brokers have issued 12 month price targets for Teligent's shares. Their predictions range from $8.00 to $11.00. On average, they expect Teligent's share price to reach $9.67 in the next twelve months.
When will Teligent announce their earnings?
Teligent is scheduled to release their next quarterly earnings announcement on Friday, October, 21st 2016.
Who owns Teligent stock?
Teligent's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Janus Capital Management LLC (10.67%), Broadfin Capital LLC (3.64%), First Light Asset Management LLC (1.80%), FMR LLC (1.56%), State Street Corp (1.22%) and Kopp Investment Advisors LLC (1.22%). Company insiders that own Teligent stock include James C Gale and Jason Grenfell-Gardner.
Who sold Teligent stock? Who is selling Teligent stock?
Teligent's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Broadfin Capital LLC, Wall Street Associates, Allianz Asset Management AG, Janus Capital Management LLC, First Light Asset Management LLC, Kopp Investment Advisors LLC and Turner Investments LLC.
Who bought Teligent stock? Who is buying Teligent stock?
Teligent's stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., State Street Corp, Ranger Investment Management L.P., Guggenheim Capital LLC, Raymond James Financial Services Advisors Inc. and Metropolitan Life Insurance Co. NY. Company insiders that have bought Teligent stock in the last two years include James C Gale and Jason Grenfell-Gardner.
How do I buy Teligent stock?
Shares of Teligent can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Teligent stock cost?
One share of Teligent stock can currently be purchased for approximately $7.23.